S Wu1, Y M Yang, J Zhu, H B Wan, J Wang, H Zhang, X H Shao. 1. Yan-min Yang, Emergency and Intensive Care Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, People's Republic of China, Tel.: (+86) 10-8839-6294; fax: (+86) 10-8836-4591, E-mail address: yymfuwai@163.com.
Abstract
OBJECTIVES: To explore the impact of age on the association between body mass index (BMI) and all-cause mortality in patients with atrial fibrillation (AF). METHODS: A total of 1991 patients with AF (69 ± 13 years, 54.9% female) were divided into three age groups: < 65 years, 65-75 years, and > 75 years, and followed for one year. The primary outcome was defined as all-cause mortality, with secondary outcomes including thromboembolism and major bleeding. Cox regression models were utilized to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS: Compared to patients aged < 65 years, elder groups had much lower BMI and more comorbidities other than a lower prevalence of valvular heart disease. During one-year follow-up, 277 (13.9%) patients died, 158 (7.9%) underwent thromboembolism events and 26 (1.3%) had major bleeding. Mortality and thromboembolism risk were both notably higher in patients with advanced age (all P values < 0.001). Using normal weight patients as reference, mortality risk was significantly lower in overweight (HR 0.548; 95% CI 0.404-0.744) and obese patients (HR 0.536; 95% CI 0.325-0.883) for the entire cohort, with reduced death risk mainly observed in overweight patients aged 65-75 years (HR 0.285; 95% CI 0.131-0.621) and aged > 75 years (HR 0.686; 95% CI 0.473-0.993), but not in patients aged < 65 years. Continuous analyses of BMI indicated consistent results. CONCLUSION: High BMI is associated with reduced mortality rate in patients with AF, and this association is affected by age, with the so-called "obesity paradox" confined to those with advanced age rather than young patients.
OBJECTIVES: To explore the impact of age on the association between body mass index (BMI) and all-cause mortality in patients with atrial fibrillation (AF). METHODS: A total of 1991 patients with AF (69 ± 13 years, 54.9% female) were divided into three age groups: < 65 years, 65-75 years, and > 75 years, and followed for one year. The primary outcome was defined as all-cause mortality, with secondary outcomes including thromboembolism and major bleeding. Cox regression models were utilized to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS: Compared to patients aged < 65 years, elder groups had much lower BMI and more comorbidities other than a lower prevalence of valvular heart disease. During one-year follow-up, 277 (13.9%) patients died, 158 (7.9%) underwent thromboembolism events and 26 (1.3%) had major bleeding. Mortality and thromboembolism risk were both notably higher in patients with advanced age (all P values < 0.001). Using normal weight patients as reference, mortality risk was significantly lower in overweight (HR 0.548; 95% CI 0.404-0.744) and obesepatients (HR 0.536; 95% CI 0.325-0.883) for the entire cohort, with reduced death risk mainly observed in overweight patients aged 65-75 years (HR 0.285; 95% CI 0.131-0.621) and aged > 75 years (HR 0.686; 95% CI 0.473-0.993), but not in patients aged < 65 years. Continuous analyses of BMI indicated consistent results. CONCLUSION: High BMI is associated with reduced mortality rate in patients with AF, and this association is affected by age, with the so-called "obesity paradox" confined to those with advanced age rather than young patients.
Entities:
Keywords:
Atrial fibrillation; age; all-cause mortality; body mass index
Authors: Abel Romero-Corral; Victor M Montori; Virend K Somers; Josef Korinek; Randal J Thomas; Thomas G Allison; Farouk Mookadam; Francisco Lopez-Jimenez Journal: Lancet Date: 2006-08-19 Impact factor: 79.321
Authors: Apurva O Badheka; Ankit Rathod; Mohammad A Kizilbash; Neha Garg; Tamam Mohamad; Luis Afonso; Sony Jacob Journal: Am J Med Date: 2010-07 Impact factor: 4.965
Authors: Nikolas Wanahita; Franz H Messerli; Sripal Bangalore; Apoor S Gami; Virend K Somers; Jonathan S Steinberg Journal: Am Heart J Date: 2007-12-19 Impact factor: 4.749
Authors: Juan Wang; Yan-min Yang; Jun Zhu; Han Zhang; Xing-hui Shao; Li Tian; Bi Huang; Li-tian Yu; Xin Gao; Man Wang Journal: Clin Res Cardiol Date: 2014-02-18 Impact factor: 5.460